Fosinopril
-
Fosinopril
structure -
-
CAS No:
98048-97-6
-
Formula:
C30H46NO7P
-
Chemical Name:
Fosinopril
-
Synonyms:
L-Proline,4-cyclohexyl-1-[2-[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-,(4S)-;L-Proline,4-cyclohexyl-1-[[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-,[1[S*(R*)],2α,4β]-;L-Proline,4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-,(4S)-;(4S)-4-Cyclohexyl-1-[2-[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-L-proline;Fosenopril;Fosinopril;Fozitec;97825-24-6;128947-97-7
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
ChEBI: A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphin nc acid, fosinoprilat, which is the active metabolite.
Fosinopril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Fosinopril is associated with a low rate of transient serum aminotransferase elevations during therapy and has been linked to rare instances of acute liver injury.|A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.
Fosinopril Basic Attributes
563.66
563.66
1806241-263-5
DTXSID1023079
C - Cardiovascular system
2942000000
Characteristics
120.02000
6.05920
Solid
1.173 g/cm3
149-153°C
705.7ºC at 760 mmHg
380.6ºC
1.531
Insoluble
Toxicity
Fosinopril, like other ACE inhibitors, has been associated with a low rate of serum aminotransferase elevations (
Drug Information
Fosinopril is an angiotensin-converting enzyme (ACE) inhibitor used in the therapy of hypertension and heart failure. Fosinopril is associated with a low rate of transient serum aminotransferase elevations during therapy and has been linked to rare instances of acute liver injury.
Angiotensin-Converting Enzyme Inhibitors
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)
Dynacil
Computed Properties
Molecular Weight:563.7
XLogP3:6.2
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:15
Exact Mass:563.30118980
Monoisotopic Mass:563.30118980
Topological Polar Surface Area:110
Heavy Atom Count:39
Complexity:850
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Fosinopril
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP
Learn More Other Chemicals
-
Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid
128948-00-5
-
Fosinopril sodium
88889-14-9
-
Dronedarone
141626-36-0
-
Zofenopril calcium Formula
81938-43-4
-
3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one Formula
86499-96-9
-
Tirofiban hydrochloride monohydrate Formula
150915-40-5
-
Saxagliptin Structure
361442-04-8
-
Dapoxetine Structure
119356-77-3
-
What is Fasudil
103745-39-7
-
What is 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
167221-71-8